MTOR and acute myeloid leukemia: Given the role of the mTOR pathway in these disorders, mTOR inhibition has been viewed with great enthusiasm as a potential treatment modality, and this enthusiasm has been matched by meaningful responses to mTOR inhibition in both AML and LAM [41, 77, 78].